Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

Epidemiology and Infection

Volumn 141, Issue 3, 2013, Pages 620-630

  Pebody, R G ^a   Andrews, N ^a   Fleming, D M ^b   McMenamin, J ^c   Cottrell, S ^d   Smyth, B ^e   Durnall, H ^b   Robertson, C ^c,f,h   Carman, W ^g   Ellis, J ^a   Sebastian Pillai, P ^a   Zambon, M ^a   Kearns, C ^e   Moore, C ^d   Thomas, D R H ^d   Watson, J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d PUBLIC HEALTH WALES   (United Kingdom)

^e PUBLIC HEALTH AGENCY   (United Kingdom)

^f UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^g West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^h INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Influenza; influenza vaccines; vaccine preventable diseases

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA B; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; SENSITIVITY ANALYSIS; UNITED KINGDOM; VACCINATION; VIRUS IDENTIFICATION; VIRUS ISOLATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; YOUNG ADULT;

EID: 84876951407     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001148     Document Type: Article

References (23)

1. Wichmann O, et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Eurosurveillance 2010; 15.
2. Valenciano M, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Medicine 2011; 8: e1000388.
3. Hardelid P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Eurosurveillance 2011; 16.
4. Andrews N, et al. Age-specific effectiveness of an oilin-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. Journal of Infectious Diseases 2011; 203: 32-39.
5. Pebody R, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Eurosurveillance 2011; 16.
6. Jimenez-Jorge S, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012; 30: 3595-3602.
7. Department of Health. Seasonal influenza vaccine uptake amongst GP patient groups in England, 2010/11 (http://www.dh.gov.uk/prod-consum-dh/groups/ dh-digitalassets/documents/digitalasset/dh-129856.pdf).
8. Skowronski DM, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 2842-2851.
9. Fleming DM, et al. Estimating Influenza vaccine effectiveness using routinely collected laboratory data. Journal of Epidemiology and Community Health 2010; 64: 1062-1067.
10. Ellis J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Eurosurveillance 2009; 14: pii=19230.
11. Gunson R, et al. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. Journal of Virological Methods 2010; 163: 258-261.
12. van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations. Journal of Statistical Software 2011; 45: 1-67.
13. Ferdinands JM, et al. Influenza vaccination status is not associated with influenza testing among children : implications for observational studies of vaccine effectiveness. Vaccine 2011; 29: 1935-1940.
14. Orenstein EW, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007; 36: 623-631.
15. Kissling E, Valenciano M. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2011; 16.
16. Fielding JE, et al. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerging Infectious Diseases 2011; 17: 1181-1187.
17. Castilla J, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Eurosurveillance 2011; 16.
18. Skowronski DM, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clinical Infectious Diseases. Published online : 21 May 2012. PMID no.: 22539661.
19. Szilagyi PG, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Archives of Pediatrics & Adolescent Medicine 2008; 162: 943-951.
20. Heinonen S, et al. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years : an observational cohort study. Lancet Infectious Diseases 2011; 11: 23-29.
21. Eisenberg KW, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008; 122: 911-919.
22. Griffin MR, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6: e23085.
23. Walker WT, et al. H1N1 antibody persistence 1 year after immunization with an adjuvanted or wholevirion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine : A multicenter follow-on study. Clinical Infectious Diseases 2012; 54: 661-669.